Note: Ingredients listed on restricted chemical lists
General Information
Version
1.1
Revision date
2024-11-15
Product name
Acetonitrile
CAS No.
75-05-8
1.2.1 Relevant identified uses
Use as laboratory reagent
Emergency telephone
+44 844 892 0111
Icons in SDS
Company Information
company name
TCI EUROPE N.V
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H302, H302+H332, H311, H319, H332, H370, H373
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Danger
Hazard statements
H225 Highly flammable liquid and vapour. H302 + H332 Harmful if swallowed or if inhaled. H311 Toxic in contact with skin. H319 Causes serious eye irritation. H370 Causes damage to organs (Respiratory system, Central nervous system). H373 May cause damage to organs (Liver, Blood, Respiratory system, Kidney, Central nervous system) through prolonged or re- peated exposure.
Prevention
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 Keep container tightly closed. P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor. P370 + P378 In case of fire: Use dry sand, dry chemical or alco- hol-resistant foam to extinguish.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupt- ing properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commis- sion Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine dis- rupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Com- mission Regulation (EU) 2018/605 at levels of 0.1% or higher.